Pulmonary vascular reactivity in severe pulmonary hypertension associated with mixed connective tissue disease.
AUTOR(ES)
Jolliet, P
RESUMO
Pulmonary vascular reactivity tests were performed in a young woman with mixed connective tissue disease and severe pulmonary hypertension. Vasoreactivity was documented in response to intravenous prostacyclin (PGI2), oral nifedipine, and inhaled nitric oxide, with quantitative differences. Nitric oxide produced a moderate lowering of pulmonary arterial pressure and resistance without any deleterious systemic effect. The use of nitric oxide in testing for pulmonary vasoreactivity merits further evaluation.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=473731Documentos Relacionados
- Recovery from pulmonary hypertension in an adolescent with mixed connective tissue disease.
- Autologous haemopoietic stem cell transplantation in a patient with severe pulmonary hypertension complicating connective tissue disease.
- The arthritis of mixed connective tissue disease.
- Morphoea (localised scleroderma) in a patient with mixed connective tissue disease.
- Selective endothelinA receptor antagonism with sitaxsentan for pulmonary arterial hypertension associated with connective tissue disease
